\-\ Texto\\:\\ \ \(0\)\
\-\ neurologic\\ exam\\:\\ slurred\\ speech\\.\\ oriented\\ only\\ to\\ year\\ and\\ name\\.\\ poor\\ concentration\\.\\ bilateral\\ nystagmus\\.\\ positive\\ for\\ weakness\\ 2\\/5\\ in\\ proximal\\ muscles\\ of\\ upper\\ and\\ lower\\ extremity\\.\\ decreased\\ vibratory\\ sensation\\ in\\ feet\\ and\\ ankles\\.\\ bilateral\\ upgoing\\ toes\\.\\ unable\\ to\\ stand\\ on\\ own\\.\\ \ \(0\)\
\-\ labs\\:\\ sodium\\ on\\ admission\\ was\\ 171\\ meq\\/l\\ with\\ glucose\\ 105mg\\/dl\\.\\ 6\\ hours\\ later\\ na\\+\\+\\ \\=169meq\\/l\\;\\ 24\\ hours\\ later\\ \\ na\\+\\+\\ \\=164\\ meq\\/l\\;\\ 48\\ hours\\ later\\ \\ na\\+\\+\\ \\=138\\ meq\\/l\\.\ \(0\)\
\-\ sodium\\ has\\ been\\ maintained\\ at\\ normal\\ levels\\.\\ patient\\ is\\ working\\ with\\ physical\\ therapy\ \(0\)\
\-\ central\\ pontine\\ mri\\ signal\\ abnormalities\\ with\\ sparing\\ of\\ the\\ peripheral\\ pontine\\ fibers\\.\\ t1\\ signal\\ hypointense\\,\\ t2\\ \\ and\\ flair\\ signal\\ hyperintense\\.\\ mild\\ diffusion\\ restriction\\ with\\ corresponding\\ low\\ adc\\.\ \(0\)\
\-\ osmotic\\ myelinolysis\\,\\ central\\ pontine\\ myelinolysis\ \(0\)\
\-\ pontine\\ ischemia\\,\\ demyelinating\\ disease\\ or\\ metabolic\\ disease\\.\ \(0\)\
\-\ 50\\ y\\.o\\.\\ man\\ with\\ etoh\\ abuse\\ presenting\\ with\\ intoxication\\ and\\ hypernatremia\\.\\ complains\\ of\\ progressive\\ upper\\ and\\ lower\\ extremity\\ weakness\\ on\\ day\\ 5\\ of\\ admission\ \(0\)\
\-\ formerly\\ known\\ as\\ central\\ pontine\\ myelinolysis\\,\\ osmotic\\ demyelination\\ syndrome\\ is\\ classically\\ seen\\ in\\ association\\ of\\ rapid\\ correction\\ of\\ hyponatremia\\ but\\ can\\ occasionally\\ be\\ seen\\ on\\ cases\\ of\\ rapid\\ correction\\ of\\ hypernatremia\\,\\ as\\ seen\\ in\\ this\\ case\\.\\ chronic\\ hypernatremia\\ should\\ be\\ corrected\\ slowly\\ due\\ to\\ the\\ risk\\ of\\ brain\\ edema\\ which\\ may\\ lead\\ to\\ brain\\ herniation\\,\\ permanent\\ neurologic\\ deficits\\ and\\ lysis\\ of\\ myelin\\.\\ in\\ this\\ case\\,\\ the\\ time\\ course\\ of\\ the\\ hypernatremia\\ was\\ unknown\\.\\ typical\\ presentation\\ is\\ usually\\ neurologic\\ deterioration\\ 48\\-72\\ hours\\ after\\ the\\ sodium\\ level\\ has\\ been\\ corrected\\.\\ pseudobulbar\\ palsy\\ and\\ spastic\\ quadriplegia\\ are\\ two\\ of\\ the\\ physical\\ findings\\ often\\ associated\\ with\\ the\\ syndrome\\.\\ \\ \\ there\\ is\\ a\\ large\\ spectrum\\ of\\ outcomes\\ ranging\\ from\\ complete\\ recovery\\ to\\ a\\ total\\ \\‚\\Ä\\úlocked\\ in\\‚\\Ä\\ù\\ state\\ which\\ may\\ progress\\ to\\ coma\\ and\\ even\\ death\\.\\ \ \(0\)\
\-\ references\\:\ \(0\)\
\-\ 1\\.\\	diagnostic\\ imaging\\:\\ brain\\.\\ osborn\\,\\ et\\ al\\.\\ 2004\\.\\ \ \(0\)\
\-\ 2\\.\\	central\\ pontine\\ myelinolysis\\.\\ luzzio\\,\\ c\\.\\ \\ e\\-medicine\\ online\\.\\ http\\:\\/\\/www\\.emedicine\\.com\\/neuro\\/topic50\\.htm\ \(0\)\
\-\ 3\\.\\	hypernatremia\\.\\ pham\\,\\ t\\.\\ e\\-medicine\\ online\\.\\ http\\:\\/\\/www\\.emedicine\\.com\\/med\\/topic1089\\.htm\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hypernatremia\\:\\ 0\\.36671022140420473\ \(0\)\
\-\ pontine\\:\\ 0\\.32913249921442067\ \(0\)\
\-\ myelinolysis\\:\\ 0\\.28368637866322877\ \(0\)\
\-\ sodium\\:\\ 0\\.16753919714838655\ \(0\)\
\-\ hours\\:\\ 0\\.14631656167469448\ \(0\)\
\-\ osmotic\\:\\ 0\\.13502032507409606\ \(0\)\
\-\ central\\:\\ 0\\.12820057525651085\ \(0\)\
\-\ online\\:\\ 0\\.12482072410552437\ \(0\)\
\-\ of\\:\\ 0\\.12209976340591709\ \(0\)\
\-\ corrected\\:\\ 0\\.11562389447757145\ \(0\)\
\-\ neurologic\\:\\ 0\\.11505226145425025\ \(0\)\
\-\ later\\:\\ 0\\.10304149177949817\ \(0\)\
\-\ correction\\:\\ 0\\.09868213565914787\ \(0\)\
\-\ brain\\:\\ 0\\.08975872604173138\ \(0\)\
\-\ rapid\\:\\ 0\\.08926533879772966\ \(0\)\
\-\ and\\:\\ 0\\.089257076031312\ \(0\)\
\-\ 48\\:\\ 0\\.08313453390870713\ \(0\)\
\-\ signal\\:\\ 0\\.08161996374115651\ \(0\)\
\-\ admission\\:\\ 0\\.08008798516007781\ \(0\)\
\-\ pseudobulbar\\:\\ 0\\.0767534764096001\ \(0\)\
\-\ luzzio\\:\\ 0\\.0767534764096001\ \(0\)\
\-\ pham\\:\\ 0\\.07334204428084096\ \(0\)\
\-\ to\\:\\ 0\\.07199101783787702\ \(0\)\
\-\ in\\:\\ 0\\.0716366781971775\ \(0\)\
\-\ http\\:\\ 0\\.07096464944994074\ \(0\)\
\-\ upgoing\\:\\ 0\\.07092159466580719\ \(0\)\
\-\ weakness\\:\\ 0\\.0700548465985203\ \(0\)\
\-\ extremity\\:\\ 0\\.06913572375032791\ \(0\)\
\-\ vibratory\\:\\ 0\\.06904414808641955\ \(0\)\
\-\ seen\\:\\ 0\\.06778610921100063\ \(0\)\
\-\ 171\\:\\ 0\\.06751016253704803\ \(0\)\
\-\ the\\:\\ 0\\.06703633765519197\ \(0\)\
\-\ formerly\\:\\ 0\\.0662131962350981\ \(0\)\
\-\ with\\:\\ 0\\.06578530968447704\ \(0\)\
\-\ hyponatremia\\:\\ 0\\.06508971292201428\ \(0\)\
\-\ spastic\\:\\ 0\\.06409873040828887\ \(0\)\
\-\ quadriplegia\\:\\ 0\\.06409873040828887\ \(0\)\
\-\ myelin\\:\\ 0\\.06321226634262662\ \(0\)\
\-\ osborn\\:\\ 0\\.06321226634262662\ \(0\)\
\-\ locked\\:\\ 0\\.06241036205276219\ \(0\)\
\-\ intoxication\\:\\ 0\\.06100483131715977\ \(0\)\
\-\ lysis\\:\\ 0\\.060381314491305176\ \(0\)\
\-\ slurred\\:\\ 0\\.05980083421386746\ \(0\)\
\-\ on\\:\\ 0\\.05798051714618131\ \(0\)\
\-\ syndrome\\:\\ 0\\.057867913913330446\ \(0\)\
\-\ name\\:\\ 0\\.05781194723878572\ \(0\)\
\-\ concentration\\:\\ 0\\.057380384598833704\ \(0\)\
\-\ deterioration\\:\\ 0\\.057380384598833704\ \(0\)\
\-\ outcomes\\:\\ 0\\.057380384598833704\ \(0\)\
\-\ ranging\\:\\ 0\\.057380384598833704\ \(0\)\
\-\ ankles\\:\\ 0\\.05696988236254601\ \(0\)\
\-\ stand\\:\\ 0\\.05696988236254601\ \(0\)\
\-\ restriction\\:\\ 0\\.05657848030896927\ \(0\)\
\-\ been\\:\\ 0\\.05592414925130154\ \(0\)\
\-\ demyelination\\:\\ 0\\.05584639904946218\ \(0\)\
\-\ etoh\\:\\ 0\\.05517294957336685\ \(0\)\
\-\ own\\:\\ 0\\.054254187476215576\ \(0\)\
\-\ permanent\\:\\ 0\\.054254187476215576\ \(0\)\
\-\ working\\:\\ 0\\.05396895247007454\ \(0\)\
\-\ nystagmus\\:\\ 0\\.053425949434428424\ \(0\)\
\-\ coma\\:\\ 0\\.053425949434428424\ \(0\)\
\-\ maintained\\:\\ 0\\.0531670481802101\ \(0\)\
\-\ demyelinating\\:\\ 0\\.05267198616812461\ \(0\)\
\-\ is\\:\\ 0\\.05257435800041235\ \(0\)\
\-\ physical\\:\\ 0\\.052047318937631704\ \(0\)\
\-\ bilateral\\:\\ 0\\.05158791137028228\ \(0\)\
\-\ upper\\:\\ 0\\.05129491638118971\ \(0\)\
\-\ toes\\:\\ 0\\.0509400237934589\ \(0\)\
\-\ sparing\\:\\ 0\\.05037259802115503\ \(0\)\
\-\ classically\\:\\ 0\\.05019165283501853\ \(0\)\
\-\ abuse\\:\\ 0\\.05001451730566926\ \(0\)\
\-\ speech\\:\\ 0\\.04950444435852115\ \(0\)\
\-\ adc\\:\\ 0\\.04950444435852115\ \(0\)\
\-\ lower\\:\\ 0\\.04905037042016925\ \(0\)\
\-\ progress\\:\\ 0\\.0488691519857887\ \(0\)\
\-\ spectrum\\:\\ 0\\.04871755100371933\ \(0\)\
\-\ fibers\\:\\ 0\\.04856863336623365\ \(0\)\
\-\ state\\:\\ 0\\.048422305732422656\ \(0\)\
\-\ may\\:\\ 0\\.048304579808811775\ \(0\)\
\-\ case\\:\\ 0\\.04822371827050052\ \(0\)\
\-\ palsy\\:\\ 0\\.047997999347229\ \(0\)\
\-\ slowly\\:\\ 0\\.04733516643641718\ \(0\)\
\-\ recovery\\:\\ 0\\.04720864334734277\ \(0\)\
\-\ death\\:\\ 0\\.047083994743487394\ \(0\)\
\-\ glucose\\:\\ 0\\.04637256043144805\ \(0\)\
\-\ occasionally\\:\\ 0\\.046038200134467244\ \(0\)\
\-\ 2004\\:\\ 0\\.045206548164099754\ \(0\)\
\-\ feet\\:\\ 0\\.04510814204966597\ \(0\)\
\-\ corresponding\\:\\ 0\\.04491471682138342\ \(0\)\
\-\ has\\:\\ 0\\.043844876906113446\ \(0\)\
\-\ which\\:\\ 0\\.04364705239417781\ \(0\)\
\-\ metabolic\\:\\ 0\\.043509186085781006\ \(0\)\
\-\ oriented\\:\\ 0\\.043269919909017504\ \(0\)\
\-\ association\\:\\ 0\\.04319165304815094\ \(0\)\
\-\ lead\\:\\ 0\\.04273675162244072\ \(0\)\
\-\ hypointense\\:\\ 0\\.042235365952131336\ \(0\)\
\-\ complains\\:\\ 0\\.04176218594684259\ \(0\)\
\-\ unable\\:\\ 0\\.04156726695435357\ \(0\)\
\-\ ischemia\\:\\ 0\\.04156726695435357\ \(0\)\
\-\ deficits\\:\\ 0\\.041252112999694474\ \(0\)\
\-\ muscles\\:\\ 0\\.04112928414860294\ \(0\)\
\-\ sensation\\:\\ 0\\.04112928414860294\ \(0\)\
\-\ flair\\:\\ 0\\.04082983521652892\ \(0\)\
\-\ poor\\:\\ 0\\.0404840210535452\ \(0\)\
\-\ diffusion\\:\\ 0\\.04042774240310105\ \(0\)\
\-\ herniation\\:\\ 0\\.04037183769993895\ \(0\)\
\-\ even\\:\\ 0\\.04037183769993895\ \(0\)\
\-\ disease\\:\\ 0\\.04029267897134076\ \(0\)\
\-\ total\\:\\ 0\\.03932531949368156\ \(0\)\
\-\ be\\:\\ 0\\.03893880980693792\ \(0\)\
\-\ as\\:\\ 0\\.03856209879556535\ \(0\)\
\-\ references\\:\\ 0\\.03826356519462455\ \(0\)\
\-\ hyperintense\\:\\ 0\\.038177270829217305\ \(0\)\
\-\ al\\:\\ 0\\.038134453297261776\ \(0\)\
\-\ levels\\:\\ 0\\.03804946644464498\ \(0\)\
\-\ presenting\\:\\ 0\\.037596790551779606\ \(0\)\
\-\ et\\:\\ 0\\.037596790551779606\ \(0\)\
\-\ typical\\:\\ 0\\.037091432441891774\ \(0\)\
\-\ progressive\\:\\ 0\\.036758542244836816\ \(0\)\
\-\ diagnostic\\:\\ 0\\.03657914041867362\ \(0\)\
\-\ unknown\\:\\ 0\\.03636878879063261\ \(0\)\
\-\ course\\:\\ 0\\.035451220708507925\ \(0\)\
\-\ abnormalities\\:\\ 0\\.03476583870045814\ \(0\)\
\-\ peripheral\\:\\ 0\\.03431997932491516\ \(0\)\
\-\ risk\\:\\ 0\\.03429288227453433\ \(0\)\
\-\ 24\\:\\ 0\\.034026606036465415\ \(0\)\
\-\ complete\\:\\ 0\\.03364235538737432\ \(0\)\
\-\ 50\\:\\ 0\\.033518075035050714\ \(0\)\
\-\ was\\:\\ 0\\.033453039461967926\ \(0\)\
\-\ labs\\:\\ 0\\.03325095333379757\ \(0\)\
\-\ presentation\\:\\ 0\\.03303853632417843\ \(0\)\
\-\ this\\:\\ 0\\.03298347273269496\ \(0\)\
\-\ cases\\:\\ 0\\.03228124422425222\ \(0\)\
\-\ positive\\:\\ 0\\.03162583742893406\ \(0\)\
\-\ should\\:\\ 0\\.03131633579691918\ \(0\)\
\-\ often\\:\\ 0\\.03131633579691918\ \(0\)\
\-\ known\\:\\ 0\\.031072988134854877\ \(0\)\
\-\ day\\:\\ 0\\.030571602464545492\ \(0\)\
\-\ usually\\:\\ 0\\.030214246093846958\ \(0\)\
\-\ only\\:\\ 0\\.02998417164819881\ \(0\)\
\-\ proximal\\:\\ 0\\.02998417164819881\ \(0\)\
\-\ t1\\:\\ 0\\.029903503466767723\ \(0\)\
\-\ decreased\\:\\ 0\\.029728709842044017\ \(0\)\
\-\ level\\:\\ 0\\.028991388079800826\ \(0\)\
\-\ edema\\:\\ 0\\.028624907536462595\ \(0\)\
\-\ two\\:\\ 0\\.028501678902668227\ \(0\)\
\-\ chronic\\:\\ 0\\.028488097581122238\ \(0\)\
\-\ time\\:\\ 0\\.028447484661375658\ \(0\)\
\-\ t2\\:\\ 0\\.02761249681828721\ \(0\)\
\-\ due\\:\\ 0\\.02758807408162945\ \(0\)\
\-\ therapy\\:\\ 0\\.02757588924695696\ \(0\)\
\-\ low\\:\\ 0\\.027539440264880508\ \(0\)\
\-\ mild\\:\\ 0\\.027206654580385504\ \(0\)\
\-\ man\\:\\ 0\\.025408825437200192\ \(0\)\
\-\ associated\\:\\ 0\\.02529664208359394\ \(0\)\
\-\ imaging\\:\\ 0\\.025222675656701995\ \(0\)\
\-\ can\\:\\ 0\\.025185934869624057\ \(0\)\
\-\ mri\\:\\ 0\\.02463606076224382\ \(0\)\
\-\ exam\\:\\ 0\\.024160399424909204\ \(0\)\
\-\ large\\:\\ 0\\.02404757132011676\ \(0\)\
\-\ but\\:\\ 0\\.023733300355226524\ \(0\)\
\-\ findings\\:\\ 0\\.02368715603368764\ \(0\)\
\-\ after\\:\\ 0\\.023282864869041582\ \(0\)\
\-\ normal\\:\\ 0\\.019595787210513017\ \(0\)\
\-\ there\\:\\ 0\\.0190968184313629\ \(0\)\
\-\ from\\:\\ 0\\.019061336557497616\ \(0\)\
\-\ are\\:\\ 0\\.01821168785122066\ \(0\)\
\-\ at\\:\\ 0\\.01812808831587938\ \(0\)\
\-\ or\\:\\ 0\\.016696393324482323\ \(0\)\
\-\ patient\\:\\ 0\\.015610165366755585\ \(0\)\
\-\ year\\:\\ 0\\.014790925759034805\ \(0\)\
\-\ for\\:\\ 0\\.014546730962374963\ \(0\)\
